A. Dafda, N. R. Singh, and A. Chhabra, “Effectiveness and safety of daily versus alternate-day rosuvastatin dose in dyslipidemic patients: a prospective, randomized and open-label study”, Int J Basic Clin Pharmacol, vol. 14, no. 1, pp. 50–54, Dec. 2024.